Lect 3 Diseasesofesophagus 121203074045 Phpapp01

Embed Size (px)

Citation preview

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    1/59

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    2/59

    Esophagus Secretes mucous, transports food no enzymes produced,

    no absorptionMucosa protection against wear and tear

    lam ina propr ia

    Submucosa

    Muscularis divided in thirds Superior 1/3 skeletal muscle

    Middle 1/3 skeletal and smooth muscle

    Inferior 1/3 smooth muscle

    2 sphincters

    upper esophageal sphincter (UES) regulatesmovement into esophagus, lower esophageal sphincter (LES)regulates movement into stomach

    Adventitia no serosa attaches to surroundings

    < 3 cm below diaphragm

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    3/59

    8/15/2013 3

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    4/59

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    5/59

    EsophagusLesions of the esophagus run from bland

    esophagitis to highly lethal cancers.

    All produce dysphagia(difficulty in swallowing),

    which is attributed either to deranged esophagealmotor function or to narrowing or obstruction of the

    lumen.

    Heartburn or Gastroesophageal reflux disease(GERD) (retrosternal burning pain) usually reflects

    regurgitation of gastric contents into the lower

    esophagus.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    6/59

    Less commonly,

    hematemesis(vomiting of

    blood) andmelena(blood

    in the stools) are evidence

    of severe inflammation,

    ulceration, or laceration of

    the esophageal mucosa. Massive hematemesis may

    reflect life-threatening

    rupture of esophageal

    varices.

    esophageal varices are extremely

    dilated sub-mucosal veins in the

    lower esophagus

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    7/59

    Patho----- Of-------Eso

    Structural abnormalities of the esophagus can be

    eithercongenital or acquired.

    The two most common congenital esophageal

    abnormalities areEsophageal Atresia (EA) and

    Tracheoesophageal Fistula (TEF).

    Anatomic disorders encountered infrequently (Table).

    8/15/2013 7

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    8/59

    Selected Anatomic Disorders Of The Esophagus

    Disorder Clinical Presentation and Anatomy

    Stenosis Adult with progressive dysphagia to solids and eventually to allfoods; a lower esophageal narrowing, which is usually the result

    of chronic inflammatory disease, including gastroesophageal

    reflux

    Atresia,

    fistula

    Newborn with aspiration, paroxysmal suffocation, pneumonia;

    esophageal atresia (absence of a lumen) and tracheoesophagealfistula may occur together

    Webs, rings Episodic dysphagia to solid foods; a (presumably) acquired

    mucosal web or mucosal and submucosal concentric ring

    partially occluding the esophagus

    Diverticula Episodic food regurgitation especially nocturnal, sometimes pain

    is present; an acquired outpouching of the esophageal wall

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    9/59

    ANATOMIC AND MOTOR DISORDERS

    Both esophageal anatomy and

    function may be affected

    secondarily by many esophageal

    disorders.

    In hiatal hernia, separation of

    the diaphragmatic crura and

    widening of the space between

    the muscular crura and the

    esophageal wall permits a

    dilated segment of the stomachto protrude above the

    diaphragm.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    10/59

    Two anatomic patterns arerecognized: the axial, or slidinghernia and the nonaxial, orparaesophageal hernia.

    The sliding hernia constitutes95% of cases; protrusion of thestomach above the diaphragm

    creates a bell-shaped dilation,bounded below by thediaphragmatic narrowing.

    In paraesophageal hernias, aseparate portion of the stomach,usually along the greatercurvature, enters the thoraxthrough the widened foramen.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    11/59

    Comparison of the two forms of esophageal

    hiatal hernias

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    12/59

    8/15/2013 12

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    13/59

    Only about 9% of these adults, however, suffer from

    heartburn or regurgitation of gastric juices into the mouth.

    Other complications affecting both types of hiatal hernias

    include mucosal ulceration, bleeding, and even perforation.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    14/59

    Achalasia The term achalasia means

    "failure to relax" and in the present

    context denotes incomplete relaxation ofthe lower esophageal sphincter in

    response to swallowing.

    Three major abnormalities in

    achalasia:

    Achalasia

    (1) Aperistalsis (absence of peristalsis )(2) partial or incomplete relaxation of the lower esophageal

    sphincter with swallowing

    (3) increased resting tone of the lower esophageal sphincter.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    15/59

    Causes

    Primary: achalasia there is loss of

    intrinsic inhibitory innervation of thelower esophageal sphincter and

    smooth muscle.

    Secondary: achalasia may arise

    from pathologic processes; exampleis Chagas disease, caused by

    Trypanosoma cruzi, which causes

    destruction of the myenteric plexus of

    the esophagus, duodenum, colon,

    and ureter.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    16/59

    Morphology

    In primary achalasia there is progressive dilation

    of the esophagus above the level of the lower

    esophageal sphincter.

    The wall of the esophagus may be normal

    thickness, thicker than normal because of

    hypertrophy of the muscularis, or markedly

    thinned by dilation.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    17/59

    Symptoms

    Backflow (regurgitation) of food

    Nocturnal regurgitation and aspiration of undigested

    food

    dysphagia

    Chest pain, which may increase after eating or may be felt

    in the back, neck, and arms

    Cough

    Difficulty swallowing liquids and solids

    Heartburn

    Unintentional weight loss

    Examination

    Esophageal manometry: is a test used to measure the function of the

    lower esophageal sphincte by specific tube through esogh to stomach

    Esophagogastroduodenoscopy

    Upper GI x-ray17

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    18/59

    Treatment

    Incurable

    Palliative measures

    Nonsurgical

    Surgical

    Both are directed toward relieving the

    obstruction caused by the no relaxing LES(

    lower esogh) Injection with botulinum toxin (Botox). This may

    help relax the sphincter muscles, but any benefit

    wears off within a matter of weeks or months.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    19/59

    Lacerations (Mallory-Weiss Syndrome)

    Longitudinal tears in the esophagus

    at the esophagogastric junction.

    The presumed pathogenesis is

    inadequate relaxation of the

    musculature of the lower esophageal

    sphincter during vomiting.

    with stretching and tearing of the

    esophagogastric junction at the

    moment of propulsive expulsion ofgastric contents.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    20/59

    This thinking is supported by the fact that a hiatal hernia is

    found in more than 75% of patients with Mallory-Weiss tears.

    Tears may involve only the mucosa or may penetrate the

    wall.

    Infection of the defect may lead to an inflammatory ulcer or to

    mediastinitis[is inflammation of the tissues in the mid-chest].

    Esophageal lacerations account for 5% to 10% of upper

    gastrointestinal bleeding episodes.

    Most often bleeding is not profuse and ceases without

    surgical intervention, but life-threatening hematemesis may

    occur.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    21/59

    ESOPHAGITIS

    Injury to the esophageal mucosa with subsequent

    inflammation is a common condition worldwide. There are many presumed contributory factors:

    Decreased efficacy of esophageal antireflux mechanisms

    Inadequate or slowed esophageal clearance of refluxed

    materialThe presence of a sliding hiatal hernia

    Increased gastric volume, contributing to the volume of

    refluxed material

    Impaired reparative capacity of the esophageal mucosa byprolonged exposure to gastric juices

    Any one of these influences may assume primacy in an

    individual case, but more than one is likely to be involved in

    most instances.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    22/59

    MORPHOLOGY

    The anatomic changes depend on the causative agent and on

    the duration and severity of the exposure.

    Mild esophagitis may appear macroscopically as simplehyperemia, with virtually no histologic abnormality.

    Three histologic features are characteristic of uncomplicated

    reflux esophagitis, although only one or two may be present:

    (1) Eosinophils, with or without neutrophils, in the epithelial

    layer;

    (2) Basal Zone Hyperplasia;

    (3) Elongation of lamina propria papillae. Intraepithelial

    neutrophils are markers ofmore severe injury.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    23/59

    23

    Reflux esophagitis showing the superficial portion of the mucosa. Numerous

    eosinophils (arrows) are present within the mucosa, and the stratified squamous

    epithelium has not undergone complete maturation owing to ongoing inflammatory

    damage.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    24/59

    8/15/2013 24

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    25/59

    Clinical Features The dominant manifestation of reflux disease is heartburn,

    sour brash.

    Difficult swallowing (dysphagia), Painful swallowing(odynophagia)

    Chest pain, particularly behind the breastbone, that occurs

    with eating Swallowed food becoming stuck in the

    esophagus (food impaction). Rarely, chronic symptoms are punctuated by attacks of

    severe chest pain mimicking a heart attack.

    The potential consequences of severe reflux esophagitis are

    bleeding, development of stricture, and Barrettesophagus, with its predisposition to malignancy.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    26/59

    BARRETT ESOPHAGUS Barrett esophagus is a complication of long-standing

    gastroesophageal reflux, occurring in up to 10% of patients

    with persistent symptomatic reflux disease, as well as in somepatients with asymptomatic reflux.

    Barrett esophagus is defined as the replacement of the normal

    distal stratified squamous mucosa by metaplastic columnar

    epithelium containing goblet cells. Prolonged and recurrent gastroesophageal reflux is thought to

    produce inflammation and eventually ulceration of the

    squamous epithelial lining.

    Healing occurs by in growth of stem cells and re-epithelialization.

    In the microenvironment of an abnormally low pH in the distal

    esophagus caused by acid reflux, the cells differentiate into

    columnar epithelium.

    MORPHOLOGY

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    27/59

    MORPHOLOGY

    Barrett esophagus is apparent as a

    salmon-pink, velvety mucosa

    between the smooth, pale pinkesophageal squamous mucosa and

    the more lush light brown gastric

    mucosa.

    the esophageal squamous

    epithelium is replaced by

    metaplastic columnarepithelium

    (gastric mucosa ).

    Critical to the pathologic evaluation

    of patients with Barrett mucosa is the

    recognition ofdysplasticchanges in

    the mucosa that may be precursors

    ofcancer.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    28/59

    8/15/2013 28

    Barrett esophagus.

    A, Endoscopic view showing red

    velvety gastrointestinal-type mucosa

    extending from the

    gastroesophageal orifice. Note palersquamous esophageal mucosa.

    B, Microscopic view showing mixed

    gastric- and intestine-type columnar

    epithelial cells in glandular mucosa.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    29/59

    Ulcer and stricture may develop as a complication of

    Barrett esophagus.

    Patients with Barrett esophagus have a 30- to 40-fold

    greater risk of developing esophageal adenocarcinomacompared with normal populations.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    30/59

    Gastroesophageal reflux disease

    (GERD)

    Gastroesophageal reflux (GER) is defined as passage ofgastric contents into the esophagus.

    GER is a normal physiologic process that occurs

    throughout the day in healthy infants, children, and adults.

    Gastroesophageal reflux disease (GERD) occurs when

    gastric contents reflux into the esophagus or oropharynx and

    produce symptoms.

    30

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    31/59

    Definitions

    GER Passage of gastric contents intoesophagus

    GERD Symptoms or complications that

    may occur when gastric contents

    reflux into esophagus or

    oropharynx

    Regurgitation Passage of refluxed gastric

    contents into oral pharynx

    Vomiting Expulsion of refluxed gastric

    contents from mouth

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    32/59

    Causes Its mostly happen becz the weakness of the lower

    esophageal sphincter, or LES

    Alcohol (possibly)

    Hiatal hernia

    Obesity

    Pregnancy

    Scleroderma (autoimmune disorder, )

    Smoking Some types of food :drinks with caffeine, fatty and

    fried foods, garlic and onions, spicy foods

    32

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    33/59

    8/15/2013 33

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    34/59

    GERD Eosinophilic esophagitisNormal esophagus

    The esophageal biopsy specimen shows a small number of

    intraepithelial eosinophils.

    Basal cell thickening of the esophageal mucosal epitheliumand lengthening of stromal papillae.

    this patient had dysphagia and food allergies that responded

    to an elimination diet.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    35/59

    Symptoms

    A burning sensation in your chest (heartburn),sometimes spreading to the throat, along with a

    sour taste in your mouth

    Chest pain

    Difficulty swallowing (dysphagia)

    Hoarseness or sore throat

    Regurgitation of food or sour liquid (acid reflux)

    Sensation of a lump in the throat

    8/15/2013 35

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    36/59

    Respiratory Symptoms of

    GER

    Apnea/ALTE

    Stridor and hoarseness Cough

    Wheezing

    Recurrent pneumonia

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    37/59

    DiagnosisEsophagoscopyTo note mucosal changes

    Esophageal biopsiesTo note changes at the cellular level

    Motilitiy studiesLow LES pressures are associated with

    reflux

    pH monitoring

    The most precise measure for thepresence of acid in the esophageallumen (24 hour monitoring)

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    38/59

    Medical Treatment

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    39/59

    Surgical TreatmentIndications for surgical treatment are somewhat

    controversialStage 0 and Stage 1 disease should never be an

    indication for surgery

    Stage 2 disease should always undergo a wellsupervised period of medical management for atleast six months to a year

    Stage 3 disease should also undergo medical

    therapy firstIn stage2 and in Stage 3 disease surgical options

    should be entertained after failed medicalmanagement

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    40/59

    Surgical Treatment

    Nissen fundoplicationTotal or partial

    Their aim is to:

    Restore normal anatomy (intra-abdominalsegment of esophagus)

    Re-creating an appropriate high-pressuresound at the esophagogastric junction

    Maintaining this repair in the normalanatomic position

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    41/59

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    42/59

    BENIGN TUMORS

    Leiomyomas

    Fibrovascular polyps

    Condylomas (hpv)

    Lipomas

    Granulation tissue

    (pseudotumor)

    ESOPHAGEAL CARCINOMA

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    43/59

    ESOPHAGEAL CARCINOMA

    There are two types: squamous cell carcinomas and

    adenocarcinomas.

    Worldwide, Squamous cell carcinomas constitute 90% ofesophageal cancers.

    Adenocarcinoma arising in Barrett esophagus is more

    common in whites than in blacks.

    There are striking and puzzling differences in the geographicincidence of esophageal carcinoma.

    In the United States, there are about 6 new cases per

    100,000 population per year.

    In regions of Asia extending from the northern provinces ofChina to Iran, the prevalence is well over 100 per 100,000.

    RISK FACTORS FOR SQUAMOUS CELL CARCINOMA OF THE

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    44/59

    RISK FACTORS FOR SQUAMOUS CELL CARCINOMA OF THE

    ESOPHAGUS

    Esophageal Disorders

    Long-standing esophagitisAchalasia

    Plummer-Vinson syndrome (esophageal webs, microcytichypochromic anemia, atrophic glossitis)

    Alcohol consumption

    Tobacco abuseDeficiency of vitamins (A, C, riboflavin, thiamine,pyridoxine)

    Deficiency of trace metals (zinc, molybdenum)

    Fungal contamination of foodstuffsHigh content of nitrites/nitrosamines

    Genetic Predisposition

    Tylosis (hyperkeratosis of palms and soles)

    MORPHOLOGY

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    45/59

    MORPHOLOGY

    Squamous cell carcinomas are usually

    early overt lesions appear as small, gray-

    white, plaque like thickenings or elevations

    of the mucosa and taking one of three

    forms:

    (1) polypoid exophytic masses that protrude

    into the lumen;

    (2) Necrotizing cancerous ulcerations that

    extend deeply and sometimes erode into the

    respiratory tree, aorta, or elsewhere

    (3) diffuse infiltrative neoplasms that impart

    thickening and rigidity to the wall and

    narrowing of the lumen.

    Large

    ulcerated

    squamous cell

    carcinoma ofthe esophagus

    Exophytic

    growing outward

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    46/59

    8/15/2013 copyright (your organization) 2003 46

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    47/59

    47

    The epithelial lining above is clearly abnormal compared to the

    normal single-layer ciliated epithelium below.

    There is nuclear stratification, nuclear enlargement,

    hyperchromasia, pleomorphism, and mitoses.

    The photomicrograph above shows pseudoinvasion but the same

    architectural and cytological features.

    Micrograph of an esophageal

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    48/59

    48

    Micrograph of an esophageal

    adenocarcinoma (dark blue - upper-left of

    image) and normal squamous epithelium

    (upper-right of image). H&E stain.

    (a) Histology of squamous cell

    carcinoma Keratinization is seen.

    (b) The tumor cells shows

    characteristic morphologies of small

    cell carcinoma.

    (c) Tubular formations are seen.

    (d) Transitional zone between squamous

    cell carcinoma element and small cellcarcinoma element of the esophageal

    carcinoma.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    49/59

    8/15/2013 49

    Microscopic Image of Esophageal

    Squamous Cell Carcinoma Microscopic image of SquamousPapilloma of the Esophagus

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    50/59

    Adenocarcinomas appear to arise from dysplastic mucosa

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    51/59

    51

    Adenocarcinomas appear to arise from dysplastic mucosa

    in the setting of Barrett esophagus.

    Unlike squamous cell carcinomas, they are usually in thedistal one third of the esophagus and may invade the

    subjacent gastric cardia.

    Microscopically, most tumors are mucin-producingglandular tumors exhibiting intestinal-type features, in

    keeping with the morphology of the preexisting metaplastic

    mucosa.

    The occasional development of tumors of other alimentary

    cell types supports the concept that Barrett epithelium

    arises from multipotential cells.

    ADENOCARCINOMA

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    52/59

    ADENOCARCINOMA

    Cli i l F t

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    53/59

    Clinical Features

    Esophageal carcinoma is insidious in onset and

    produces dysphagia and obstruction gradually and

    late.

    Weight loss, anorexia, fatigue, and weaknessappear, followed by pain, usually related to

    swallowing.

    Because these cancers extensively invade the rich

    esophageal lymphatic network and adjacent

    structures, surgical excision rarely is curative.

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    54/59

    Diagnosis is usually made by imaging techniques

    and endoscopic biopsy.

    Esophagogastroduod enoscopy

    8/15/2013 copyright (your organization) 2003 54

    Diagnosis

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    55/59

    QUIZ

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    56/59

    8/15/2013 copyright (your organization) 2003 56

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    57/59

    8/15/2013 copyright (your organization) 2003 57

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    58/59

    8/15/2013 copyright (your organization) 2003 58

  • 7/27/2019 Lect 3 Diseasesofesophagus 121203074045 Phpapp01

    59/59